Document is current
Any future updates will be listed below
-
Authors
Feng, Bing https://orcid.org/0000-0002-6108-2017
Bai, Zhiliang https://orcid.org/0000-0002-3977-3057
Zhou, Xiaolei
Zhao, Yang https://orcid.org/0000-0002-6596-499X
Xie, Yu-Qing
Huang, Xinyi https://orcid.org/0000-0003-4808-5173
Liu, Yang
Enbar, Tom
Li, Rongrong
Wang, Yi
Gao, Min
Bonati, Lucia
Peng, Mei-Wen
Li, Weilin
Tao, Bo https://orcid.org/0000-0002-5490-4668
Charmoy, Mélanie
Held, Werner https://orcid.org/0000-0003-3292-1536
Melenhorst, J. Joseph https://orcid.org/0000-0001-7677-537X
Fan, Rong https://orcid.org/0000-0001-7805-8059
Guo, Yugang https://orcid.org/0000-0003-4499-8274
- License Information
-
More Information
Article History
Received: 29 May 2023
Accepted: 20 August 2024
First Online: 25 September 2024
Competing interests
: Y.G., L.T. and B.F. are inventors of the patents relevant to the findings reported here. L.T. and Y.G. are cofounders, share-holders and advisors for Leman Biotech. The interests of L.T. were reviewed and managed by EPFL. R.F. is scientific founder and adviser for IsoPlexis, Singleron Biotechnologies and AtlasXomics. The interests of R.F. were reviewed and managed by Yale University Provost’s Office in accordance with the University’s conflict of interest policies. J.J.M. hold patents related to CAR-T cell manufacturing and biomarker discovery. The remaining authors declare no competing interests.
